New York State Common Retirement Fund’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4
Closed -$1.35K 3281
2023
Q2
$1.35K Sell
4
-177
-98% -$79.9K ﹤0.01% 3298
2023
Q1
$120K Sell
181
-127
-41% -$113K ﹤0.01% 2762
2022
Q4
$270K Hold
308
﹤0.01% 2591
2022
Q3
$338K Buy
308
+1
+0.3% +$1.32K ﹤0.01% 2534
2022
Q2
$255K Sell
307
-1
-0.3% -$1.03K ﹤0.01% 2681
2022
Q1
$477K Hold
308
﹤0.01% 2425
2021
Q4
$552K Sell
308
-1
-0.3% -$2.67K ﹤0.01% 2382
2021
Q3
$1.02M Sell
309
-93
-23% -$325K ﹤0.01% 2101
2021
Q2
$1.77M Buy
+402
New +$1.59M ﹤0.01% 1949

Other funds holding BNGO

New York State Common Retirement Fund's BNGO Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 4 shares — an estimated $1.35K sold.

New York State Common Retirement Fund first reported a position in BNGO in Q2 2021 and held it in 9 quarters. The position peaked at $1.77M in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • New York State Common Retirement Fund reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 4 Bionano Genomics shares in Q3 2023, an estimated $1.35K.
  • New York State Common Retirement Fund first reported a position in Bionano Genomics in Q2 2021 and held it in 9 quarters.
  • New York State Common Retirement Fund's Bionano Genomics position peaked at $1.77M in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.